The GW Cancer Center’s Gastrointestinal Cancer Program is a comprehensive initiative dedicated to treating cancers of the gastrointestinal tract, including colorectal, liver, and pancreatic, with advanced treatment therapies.
Our team consists of nationally renowned specialists in gastroenterology, medical and radiation oncology, and interventional radiology. We also collaborate across GW with experts in colorectal, hepatobiliary, pancreatic, and thoracic surgery. The program is recognized for its multidisciplinary, patient-centered approach that combines advanced diagnosis and treatment options.
We employ leading-edge technologies in our treatment protocols, such as the da Vinci® Xi robotic system for minimally-invasive surgeries and resections, as well as the Medrobotics Flex™ Robotic System. In addition to chemotherapy and advanced stereostactic body radiation, we treat eligible patients with systematic therapies, including immunotherapy and targeted therapies (drugs that work at the molecular level to stop cancer).
Research and Clinical Trials
Gastrointestinal cancer research at the GW Cancer Center is designed to investigate the various biological, genetic, and environmental factors contributing to gastrointestinal cancers, develop new treatments, and enhance existing ones. Our community-based research is focused on understanding and reducing gastrointestinal cancer disparities in the DC-metro region, including colon and liver cancer, special populations affected by HIV and anal cancer.
GW Liver and Pancreas Institute for Quality
The GW Liver and Pancreas Institute for Quality (LPIQ) offers innovative, state-of-the-art treatments for patients with pancreatic, liver, bile duct, duodenum, and gallbladder diseases.
Executive Director Lynt Johnson, MD, MBA, and the LPIQ team have more than 80 years of combined experience in hepatobiliary surgery and treatments. With well over 1000 combined pancreas resections and 700 liver resections, LPIQ offers nationally superior outcomes in a specialized, multidisciplinary environment.
Patients have access to surgical approaches for the most complex conditions, interventional ablative techniques, vascular reconstruction, targeted precision drug therapies, advanced stereotactic body radiation treatment, multidisciplinary oncologic pre-treatment planning, clinical trials, and perioperative care. In addition, our Advanced Nurse Practitioners and Program Manager provide personalized care with informative and open communication between patients and referring physician caregivers.